Review Article

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

Figure 1

Recommended treatment strategy for patients with acute, lymphoma, or chronic/smoldering ATL (CR: complete remission; MRD: minimal residual disease; AZT: zidovudine; IFN: interferon-alpha; alloSCT: allogeneic stem cell transplantation).
932175.fig.001